Cellectis S.A. to Explore Possible Initial Public Offering of Calyxt, Inc.
April 12 2017 - 5:00PM
Business Wire
Regulatory News:
Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Alternext: ALCLS; Nasdaq:
CLLS) today announces that it is exploring the possibility of an
initial public offering (IPO) of a minority interest in its plant
sciences business, Calyxt, Inc. No decisions have been taken at
this point on the structure or timing of any IPO, and no assurance
can be given that an IPO will be pursued.
This press release contains inside information within the
meaning of Article 7(1) of the EU Market Abuse Regulation.
This press release is being made pursuant to, and in accordance
with, Rule 135 under the Securities Act of 1933, as amended. This
press release does not constitute an offer to sell or the
solicitation of an offer to buy securities, and shall not
constitute an offer, solicitation or sale in any jurisdiction in
which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of that
jurisdiction.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170412006204/en/
Media:Jennifer Moore, 917-580-1088VP of
Communicationsmedia@cellectis.comorCaitlin Kasunich,
212-896-1241KCSA Strategic
Communicationsckasunich@kcsa.comIR:Simon Harnest,
646-385-9008VP of Corporate Strategy and
Financesimon.harnest@cellectis.com
Cellectis (NASDAQ:CLLS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cellectis (NASDAQ:CLLS)
Historical Stock Chart
From Apr 2023 to Apr 2024